Structural Bases for the Synergistic Inhibition of Human Thymidylate Synthase and Ovarian Cancer Cell Growth by Drug Combinations
Authors:
- Cecilia PozziCecilia Pozzi
- Matteo SantucciMatteo Santucci
- Gaetano MarvertiGMGaetano Marverti
- Domenico D’arcaDDDomenico D’arca
- Lorenzo TagliazucchiLTLorenzo Tagliazucchi
- Stefania FerrariSFStefania Ferrari
- Gaia GozziGGGaia Gozzi
- Lorena LosiLorena Losi
- Giusy TassoneGiusy Tassone
- Stefano ManganiStefano Mangani
- Glauco PonteriniGPGlauco Ponterini
- Maria Paola CostiMCMaria Paola Costi
Open Access
Abstract
Combining drugs represent an approach to efficiently prevent and overcome drug resistance and to reduce toxicity; yet it is a highly challenging task, particularly if combinations of inhibitors of the same enzyme target are considered. To show that crystallographic and inhibition kinetic information can provide indicators of cancer cell growth inhibition by combinations of two anti-human thymidylate synthase (hTS) drugs, we obtained the X-ray crystal structure of the hTS:raltitrexed:5-fluorodeoxyuridine monophosphate (FdUMP) complex. Its analysis showed a ternary complex with both molecules strongly bound inside the enzyme catalytic cavity. The synergistic inhibition of hTS and its mechanistic rationale were consistent with the structural analysis. When administered in combination to A2780 and A2780/CP ovarian cancer cells, the two drugs inhibited ovarian cancer cell growth additively/synergistically. Together, these results support the idea that X-ray crystallography can provide structural indicators for designing combinations of hTS (or any other target)-directed drugs to accelerate preclinical research for therapeutic application.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (IG 16977)
This publication has 51 references indexed in Scilit:
- Autoindexing diffraction images withiMosflmActa Crystallographica Section D Structural Biology, 2013
- Transcriptional Activation and Cell Cycle Block Are the Keys for 5-Fluorouracil Induced Up-Regulation of Human Thymidylate Synthase ExpressionPLOS ONE, 2012
- Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthaseProceedings of the National Academy of Sciences, 2011
- REFMAC5 for the refinement of macromolecular crystal structuresActa Crystallographica Section D Structural Biology, 2011
- Overview of theCCP4 suite and current developmentsActa Crystallographica Section D Structural Biology, 2011
- An introduction to data reduction: space-group determination, scaling and intensity statisticsActa Crystallographica Section D Structural Biology, 2011
- Features and development of CootActa Crystallographica Section D Structural Biology, 2010
- The R163K Mutant of Human Thymidylate Synthase Is Stabilized in an Active Conformation: Structural Asymmetry and Reactivity of Cysteine 195Biochemistry, 2008
- Scaling and assessment of data qualityActa Crystallographica Section D Structural Biology, 2005
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004